Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to -$4.1 million.

  • Apyx Medical's Free Cash Flow rose 1171.35% to -$4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.5 million, marking a year-over-year increase of 4694.84%. This contributed to the annual value of -$18.8 million for FY2024, which is 22461.09% down from last year.
  • Latest data reveals that Apyx Medical reported Free Cash Flow of -$4.1 million as of Q3 2025, which was up 1171.35% from -$1.5 million recorded in Q2 2025.
  • In the past 5 years, Apyx Medical's Free Cash Flow registered a high of $3.5 million during Q3 2023, and its lowest value of -$6.4 million during Q1 2024.
  • Its 5-year average for Free Cash Flow is -$3.3 million, with a median of -$4.1 million in 2025.
  • Per our database at Business Quant, Apyx Medical's Free Cash Flow plummeted by 385932.2% in 2022 and then surged by 16348.23% in 2023.
  • Apyx Medical's Free Cash Flow (Quarter) stood at -$118000.0 in 2021, then crashed by 3859.32% to -$4.7 million in 2022, then soared by 50.66% to -$2.3 million in 2023, then crashed by 38.05% to -$3.2 million in 2024, then dropped by 27.44% to -$4.1 million in 2025.
  • Its last three reported values are -$4.1 million in Q3 2025, -$1.5 million for Q2 2025, and -$757000.0 during Q1 2025.